All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

267

Reset

267 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • celiprololACER-002Phase 31 trial

    Acer Therapeutics Inc. · Vascular Ehlers-Danlos Syndrome

  • GB06Phase 31 trial

    Kexing Biopharm Co., Ltd. · Growth Hormone Deficiency (GHD), Growth Hormone Deficiency in Children, Growth Hormone Deficiency, Pediatric

  • GC5107GCC 10% IGIVPhase 31 trial

    GC Biopharma Corp · Primary Immune Deficiency

  • GNR-055GNR-055 1.0-2.0Phase 31 trial

    AO GENERIUM · Mucopolysaccharidosis Type II, Metabolic Diseases

  • IgPro20Immune Globulin 20% LiquidPhase 31 trial

    CSL Behring · Secondary Immune Deficiency

  • KK8398Phase 31 trial

    Kyowa Kirin Co., Ltd. · Achondroplasia

  • KP-001Phase 31 trial

    Kaken Pharmaceutical · Venous Malformations, Lymphatic Malformations, Klippel-Trenaunay Syndrome

  • NTLA-2002Phase 31 trial

    Intellia Therapeutics · Hereditary Angioedema

  • NVD003Phase 31 trial

    Novadip Biosciences · Congenital Pseudarthrosis of Tibia

  • NXC-201Phase 31 trial

    Nexcella Inc. · Light Chain (AL) Amyloidosis

  • PJ009Phase 31 trial

    Chongqing Peg-Bio Biopharm Co., Ltd. · Short Bowel Syndrome

  • RilogrotugPhase 31 trial

    AVEO Pharmaceuticals, Inc. · Cachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome

  • RT001Deuterated linoleic acidPhase 31 trial

    Biojiva LLC · Infantile Neuroaxonal Dystrophy

  • rugonersenPhase 31 trial

    OHB Pediatrics Ltd. · Angelman Syndrome

  • SRP-9003Phase 31 trial

    Sarepta Therapeutics, Inc. · Limb-girdle Muscular Dystrophy

  • THRV-1268Phase 31 trial

    Thryv Therapeutics · Long QT Syndrome (LQTS) 2

  • NM8074Phase 28 trials

    NovelMed Therapeutics · Paroxysmal Nocturnal Hemoglobinuria, Dermatomyositis, PNH - Paroxysmal Nocturnal Hemoglobinuria

  • UC-MSCRY_SW01 cell, Human umbilical cord mesenchymal stem cellsPhase 28 trials

    Jiangsu Renocell Biotech Company · Acute Respiratory Distress Syndrome, Lupus Nephritis, Spinocerebellar Ataxia Type 1

  • AtibuclimabIC14Phase 24 trials

    Implicit Bioscience · Acute Respiratory Distress Syndrome, Adult Respiratory Distress Syndrome, Acute Lung Injury

  • DabogratinibTYRA-300Phase 24 trials

    Tyra Biosciences, Inc · FGFR3 Gene Mutation, FGFR3 Gene Alteration, Achondroplasia

  • Descartes-08Phase 24 trials

    Cartesian Therapeutics · Myasthenia Gravis, Generalized, Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV)

  • MAS825ArumakimigPhase 24 trials

    Novartis · NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations, Still´s Disease, VEXAS Syndrome

  • RimonabantPhase 24 trials

    Sinfatin S.L · Chronic Stroke, Subacute Stroke, Post-COVID-19 Syndrome

  • SecretomeConditioned, Umbilical Cord Mesenchymal Stem Cells derived ConditionedPhase 24 trials

    PT. Prodia Stem Cell Indonesia · Acute Respiratory Distress Syndrome, Androgenetic Alopecia, Ischemic Stroke

  • SevasemtenPhase 24 trials

    Edgewise Therapeutics, Inc. · Becker Muscular Dystrophy, Duchenne Muscular Dystrophy

  • AP1189Phase 23 trials

    SynAct Pharma Aps · Rheumatoid Arthritis (RA), Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy

  • BrogidirsenNS-089, NCNP-02Phase 23 trials

    NS Pharma, Inc. · Duchenne Muscular Dystrophy, Exon 44, DMD

  • ESG206ESG206-2Phase 23 trials

    Shanghai Escugen Biotechnology Co., Ltd · Systemic Lupus Erythematosus (SLE), Immune Thrombocytopenia (ITP), Primary Sjögren Syndrome

  • ETX101Phase 23 trials

    Encoded Therapeutics · Dravet Syndrome

  • Lu AG13909AsedebartPhase 23 trials

    H. Lundbeck A/S · Cushing's Disease, Congenital Adrenal Hyperplasia, Adrenal Hyperplasia, Congenital

  • RimiducidAP1903Phase 23 trials

    Bellicum Pharmaceuticals · Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Leukemia, Acute Myeloid (AML), Child

  • RVU120SEL120Phase 23 trials

    Ryvu Therapeutics SA · Advanced Solid Tumors, Acute Myeloid Leukaemia (AML), High-risk Myelodysplastic Syndrome

  • SPI-62clofutriben, ASP3662Phase 23 trials

    Sparrow Pharmaceuticals · Cortisol Excess, Type 2 Diabetes, Polymyalgia Rheumatica

  • 4D-310Phase 22 trials

    4D Molecular Therapeutics · Fabry Disease

  • ABSK061Phase 22 trials

    Abbisko Therapeutics Co, Ltd · HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer

  • ALN-6400Phase 22 trials

    Alnylam Pharmaceuticals · Von Willebrand Disease (VWD), Heavy Menstrual Bleeding (HMB), Hereditary Hemorrhagic Telangiectasia

  • bexmarilimabFP-1305Phase 22 trials

    Faron Pharmaceuticals Ltd · Higher Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia

  • BLEX 404 LiquidPhase 22 trials

    BioLite, Inc. · Myelodysplastic Syndrome (MDS), Triple Negative Breast Cancer

  • BMB-101Phase 22 trials

    Bright Minds Biosciences Pty Ltd · Absence Epilepsy, Jeavons Syndrome, Dravet Syndrome

  • BMN 351Phase 22 trials

    BioMarin · Duchenne Muscular Dystrophy (DMD), Duchenne Muscular Dystrophy

  • DibotatugDR-01Phase 22 trials

    Dren Bio · Bone Marrow Failure Syndromes, Aplastic Anemias, Severe Aplastic Anemia (SAA)

  • DISC-0974Phase 22 trials

    Disc Medicine, Inc · Anemia, Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia

  • ENTR-601-44Phase 22 trials

    Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)

  • ENTR-601-45Phase 22 trials

    Entrada Therapeutics, Inc. · Duchenne Muscular Dystrophy (DMD)

  • FKC289Phase 22 trials

    Shenzhen Fosun Kairos Biotechnology Co., Ltd. · Primary Membranous Nephropathy, Primary Light Chain (AL) Amyloidosis

  • GenSci134Phase 22 trials

    Changchun GeneScience Pharmaceutical Co., Ltd. · Pediatric Growth Hormone Deficiency, Idiopathic Short Stature

  • Laboratoires Thea · Retinitis Pigmentosa (RP), Usher Syndrome Type 2, Deaf Blind

  • JR-446Phase 22 trials

    JCR Pharmaceuticals Co., Ltd. · Mucopolysaccharidosis III-B, Mucopolysaccharidosis IIIB

  • mivelsiranALN-APPPhase 22 trials

    Alnylam Pharmaceuticals · Cerebral Amyloid Angiopathy, Down Syndrome-Associated Alzheimer's Disease (DS-AD)

  • OfirnoflastHT-6184Phase 22 trials

    Halia Therapeutics, Inc. · Myelodysplastic Syndromes, Anemia, Myelodysplastic Syndrome

NewerPage 3 of 6Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.